ATE429232T1
Immunemodulating oligosaccharides
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 25 October 2024, 1.9 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
60 members in 20 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 03078375 | European Patent Office (EPO) | A | |
| 04076877 | European Patent Office (EPO) | A |
Members60
| Document | Office | Kind | |
|---|---|---|---|
| AU2004283628A1 | Australia | A1 | |
| AU2004283628A2 | Australia | A2 | |
| CA2542996A1 | Canada | A1 | |
| WO2005039597A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2005039597A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1675595A2 | European Patent Office (EPO) | A2 | |
| EP1721612A2 | European Patent Office (EPO) | A2 | |
| CN1871015A | China | A | |
| EP1733730A2 | European Patent Office (EPO) | A2 | |
| BRPI0415699A | Brazil | A | |
| EP1733730A3 | European Patent Office (EPO) | A3 | |
| US2007098762A1 | United States of America | A1 | |
| EP1721612A3 | European Patent Office (EPO) | A3 | |
| JP2007525483A | Japan | A | |
| ZA200603166B | South Africa | B | |
| RU2006117784A | Russian Federation | A | |
| EP1911453A2 | European Patent Office (EPO) | A2 | |
| EP1935425A2 | European Patent Office (EPO) | A2 | |
| EP1733730B1 | European Patent Office (EPO) | B1 | |
| AT400278T | Austria | T | |
| ATE400278T1 | Austria | T1 | |
| DE602004014992D1 | Germany | D1 | |
| EP1911453A3 | European Patent Office (EPO) | A3 | |
| EP1935425A3 | European Patent Office (EPO) | A3 | |
| DK1733730T3 | Denmark | T3 | |
| PT1733730E | Portugal | E | |
| ES2309901T3 | Spain | T3 | |
| PL1733730T3 | Poland | T3 | |
| SI1733730T1 | Slovenia | T1 | |
| EP1721612B1 | European Patent Office (EPO) | B1 | |
| AT429232T | Austria | T | |
| ATE429232T1This record | Austria | T1 | |
| SG152270A1 | Singapore | A1 | |
| SG152271A1 | Singapore | A1 | |
| DK1721612T3 | Denmark | T3 | |
| DE602004020809D1 | Germany | D1 | |
| NZ546785A | New Zealand | A | |
| ES2324369T3 | Spain | T3 | |
| SI1721612T1 | Slovenia | T1 | |
| PT1721612E | Portugal | E | |
| PL1721612T3 | Poland | T3 | |
| EP2123282A2 | European Patent Office (EPO) | A2 | |
| EP2123282A3 | European Patent Office (EPO) | A3 | |
| RU2388478C2 | Russian Federation | C2 | |
| CN1871015B | China | B | |
| AU2004283628B2 | Australia | B2 | |
| EP2223691A1 | European Patent Office (EPO) | A1 | |
| AU2010235987A1 | Australia | A1 | |
| NZ577220A | New Zealand | A | |
| CN101987107A | China | A | |
| EP2305269A2 | European Patent Office (EPO) | A2 | |
| EP2305269A3 | European Patent Office (EPO) | A3 | |
| RU2010102704A | Russian Federation | A | |
| JP4943853B2 | Japan | B2 | |
| US8557794B2 | United States of America | B2 | |
| CY1108342T1 | Cyprus | T1 | |
| CA2542996C | Canada | C | |
| CY1110353T1 | Cyprus | T1 | |
| EP2305269B1 | European Patent Office (EPO) | B1 | |
| ES2781848T3 | Spain | T3 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 6115301
Titles2
- German
- IMMUNMODULIERENDE OLIGOSACCHARIDE
- English
- IMMUNOMODULATING OLIGOSACCHARIDES
Classification
- CPC, 29
- A61K31/732
- A23V2002/00
- A61K31/70
- A61K31/702
- A23L29/30
- A23L33/40
- A23L33/10
- A23L33/125
- A61P1/04
- A61P11/00
- A61P13/12
- A61P17/00
- A61P17/06
- A61P21/04
- A61P25/00
- A61P29/00
- A61P31/12
- A61P31/18
- A61P3/08
- A61P37/00
- A61P37/02
- A61P37/04
- A61P37/06
- A61P37/08
- A61P43/00
- A61P7/00
- A61P7/06
- A61P9/00
- A61P3/10
- IPC, 4
- A23L33 00
- A61K31 70
- A61K31 702
- A61K31 732